SpectraCure AB (OSTO:SPEC) ROE % Adjusted to Book Value: -50.64% (As of Mar. 2026)

What is SpectraCure AB ROE % Adjusted to Book Value?

SpectraCure AB OSTO:SPEC -4.65% ROE % Adjusted to Book Value is -50.64% as of Mar. 2026. The stock has 1 warning sign investors should review.

SpectraCure AB's ROE % for the quarter that ended in Mar. 2026 was -25.32%. SpectraCure AB's PB Ratio for the quarter that ended in Mar. 2026 was 0.50. SpectraCure AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -50.64%.

SpectraCure AB ROE % Adjusted to Book Value Related Terms

SpectraCure AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB ROE % Adjusted to Book Value Chart

SpectraCure AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-3.85

-4.81

-5.05

-8.42

-82.31

SpectraCure AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.61	-59.68	-142.98	-45.66	-50.64

OSTO:SPEC vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, SpectraCure AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SpectraCure AB ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SpectraCure AB's ROE % Adjusted to Book Value falls into.

Save Embed

SpectraCure AB ROE % Adjusted to Book Value Calculation

SpectraCure AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-55.97%	/	0.68
	=	-82.31%

SpectraCure AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-25.32%	/	0.50
	=	-50.64%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of -50.64% mean?

SpectraCure AB (OSTO:SPEC) has a ROE % Adjusted to Book Value of -50.64% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on SpectraCure AB and its competitors.

Is SpectraCure AB's ROE % Adjusted to Book Value too high?

SpectraCure AB's current ROE % Adjusted to Book Value is -50.64%.

How does SpectraCure AB's ROE % Adjusted to Book Value compare to ABT and SYK?

SpectraCure AB's ROE % Adjusted to Book Value of -50.64% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?

A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current ROE % Adjusted to Book Value is -50.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is SpectraCure AB stock overvalued right now?

SpectraCure AB (OSTO:SPEC) has a current ROE % Adjusted to Book Value of -50.64%. The current ROE % Adjusted to Book Value is -50.64%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current ROE % Adjusted to Book Value is -50.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:SDOS OSTO:QLIFE XSAT:REDS XSAT:POLAR XSAT:VSD B XSAT:BIBB OSTO:NEOLA OSTO:PERP B XSAT:PEXA B XSAT:ZENI ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Address Magistratsvagen 10, Lund, SWE, 22643

Website http://www.spectracure.com

SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.